Deutsch English Français

Contact

EP3762009

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

Latvia joins the Federated Register
Click here for more information on the Federated Register.

2025-04-16

More...

Extract from the Register of European Patents

EP About this file: EP3762009

EP3762009 - TOXIN-DERIVED DELIVERY CONSTRUCTS FOR ORAL DELIVERY [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 17.03.2023 Database last updated on 26.04.2025
Former	The patent has been granted Status updated on 08.04.2022
Former	Grant of patent is intended Status updated on 25.11.2021
Former	Examination is in progress Status updated on 21.05.2021
Former	Request for examination was made Status updated on 11.12.2020
Former	The international publication has been made Status updated on 14.09.2019
Former	unknown Status updated on 19.04.2019
Most recent event Tooltip	15.11.2024	Change - lapse in a contracting state Updated state(s): BG	published on 18.12.2024 [2024/51]
Applicant(s)	For all designated states Applied Molecular Transport Inc. 450 East Jamie Court South San Francisco, CA 94080 / US
	[2022/17]
Former [2021/02]	For all designated states Applied Molecular Transport Inc. 1 Tower Place, Suite 850 South San Francisco, CA 94080 / US
Inventor(s)	01 / MRSNY, Randall J. 1 Tower Place, Suite 850 South San Francisco, California 94080 / US
	02 / LIU, Keyi 1 Tower Place, Suite 850 South San Francisco, California 94080 / US
	03 / MACKAY, Julia Dawn 1 Tower Place, Suite 850 South San Francisco, California 94080 / US
	04 / FENG, Weijun 1 Tower Place, Suite 850 South San Francisco, California 94080 / US
	05 / HUNTER, Thomas Carl 1 Tower Place, Suite 850 South San Francisco, California 94080 / US
	06 / MAHMOOD, Tahir 1 Tower Place, Suite 850 South San Francisco, California 94080 / US
	07 / TAVERNER, Alistair 1 Tower Place, Suite 850 South San Francisco, California 94080 / US
	[2021/29]
Former [2021/02]	01 / MRSNY, Randall J. 1 Tower Place, Suite 850 South San Francisco, California 94080 / US
	02 / LIU, Keyi 1 Tower Place, Suite 850 South San Francisco, California 94080 / US
	03 / MACKAY, Julia Dawn 1 Tower Place, Suite 850 South San Francisco, California 94080 / US
	04 / FENG, Weijun 1 Tower Place, Suite 850 South San Francisco, California 94080 / US
	05 / HUNTER, Thomas Carl 1 Tower Place, Suite 850 South San Francisco, California 94080 / US
Representative(s)	Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
	[2022/19]
Former [2021/02]	Marshall, Cameron John Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
Application number, filing date	19717013.7	08.03.2019
	[2021/02]
	WO2019US21474
Priority number, date	US201862640188P	08.03.2018 Original published format: US 201862640188 P
	US201862640194P	08.03.2018 Original published format: US 201862640194 P
	US201862640168P	08.03.2018 Original published format: US 201862640168 P
	US201862756889P	07.11.2018 Original published format: US 201862756889 P
	[2021/32]
Former [2021/02]	US201862640188P	08.03.2018
	US201862640194P	08.03.2018
	US201862640168P	08.03.2018
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2019173787
	Date:	12.09.2019
	Language:	EN
	[2019/37]
	Type:	A1 Application with search report
	No.:	EP3762009
	Date:	13.01.2021
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 12.09.2019 takes the place of the publication of the European patent application.
	[2021/02]
	Type:	B1 Patent specification
	No.:	EP3762009
	Date:	11.05.2022
	Language:	EN
	[2022/19]
Search report(s)	International search report - published on:	EP	12.09.2019
Classification	IPC:	C12N9/10, C07K14/21, C07K14/28, A61K38/00, A61K38/16, A61K47/64, A61K47/65	[2021/49]
	CPC:	A61K38/21 (EP,US); C07K14/28 (EP,IL,KR); A61K47/64 (KR); A61K47/6415 (EP,IL,KR,US); A61K38/00 (EP,IL); A61K38/19 (KR); (+) A61K38/27 (US); A61K47/65 (EP,IL,KR,US); A61K9/0043 (EP,US); A61K9/007 (US); A61P1/00 (EP); A61P1/16 (KR); A61P29/00 (KR); A61P3/00 (KR); A61P35/00 (KR); A61P37/00 (KR); C07K14/21 (EP,IL,KR); C07K14/5428 (KR); C07K14/62 (KR); C07K16/241 (KR); C12N9/1077 (EP,IL); C12Y204/02036 (EP,IL); A61K2039/505 (KR); A61K9/0053 (KR); A61K9/0073 (EP); C07K2319/60 (KR) (-)
	Former IPC [2021/02]	A61K38/16, C07K14/21, C07K14/28, A61K47/64, C12N9/10
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/02]
Extension states	BA	Not yet paid
	ME	Not yet paid
Validation states	KH	Not yet paid
	MA	Not yet paid
	MD	Not yet paid
	TN	Not yet paid
Title	German:	VON TOXINEN ABGELEITETE KONSTRUKTE ZUR ORALEN VERABREICHUNG	[2021/02]
	English:	TOXIN-DERIVED DELIVERY CONSTRUCTS FOR ORAL DELIVERY	[2021/02]
	French:	CONSTRUCTIONS D'ADMINISTRATION DÉRIVÉES DE TOXINES POUR ADMINISTRATION ORALE	[2021/02]
Entry into regional phase	08.10.2020	National basic fee paid
	08.10.2020	Designation fee(s) paid
	08.10.2020	Examination fee paid
Examination procedure	08.10.2020	Examination requested [2021/02]
	08.10.2020	Date on which the examining division has become responsible
	10.02.2021	Amendment by applicant (claims and/or description)
	20.05.2021	Despatch of a communication from the examining division (Time limit: M04)
	02.09.2021	Reply to a communication from the examining division
	26.11.2021	Communication of intention to grant the patent
	04.04.2022	Fee for grant paid
	04.04.2022	Fee for publishing/printing paid
	04.04.2022	Receipt of the translation of the claim(s)
Divisional application(s)	EP22165874.3 / EP4082558
	EP23192492.9 / EP4316586
Opposition(s)	14.02.2023	No opposition filed within time limit [2023/16]
Fees paid	Renewal fee
	29.03.2021	Renewal fee patent year 03
	28.03.2022	Renewal fee patent year 04
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	AL	11.05.2022
	BG	11.05.2022
	EE	11.05.2022
	HR	11.05.2022
	LT	11.05.2022
	LV	11.05.2022
	MC	11.05.2022
	RO	11.05.2022
	RS	11.05.2022
	SM	11.05.2022
	IS	11.09.2022
	[2024/51]
Former [2023/48]	AL	11.05.2022
	EE	11.05.2022
	HR	11.05.2022
	LT	11.05.2022
	LV	11.05.2022
	MC	11.05.2022
	RO	11.05.2022
	RS	11.05.2022
	SM	11.05.2022
	BG	11.08.2022
	IS	11.09.2022
Former [2023/17]	AL	11.05.2022
	EE	11.05.2022
	HR	11.05.2022
	LT	11.05.2022
	LV	11.05.2022
	RO	11.05.2022
	RS	11.05.2022
	SM	11.05.2022
	BG	11.08.2022
	IS	11.09.2022
Former [2023/09]	EE	11.05.2022
	HR	11.05.2022
	LT	11.05.2022
	LV	11.05.2022
	RO	11.05.2022
	RS	11.05.2022
	SM	11.05.2022
	BG	11.08.2022
	IS	11.09.2022
Former [2022/51]	HR	11.05.2022
	LT	11.05.2022
	LV	11.05.2022
	RS	11.05.2022
	BG	11.08.2022
	IS	11.09.2022
Former [2022/50]	HR	11.05.2022
	LT	11.05.2022
	LV	11.05.2022
	RS	11.05.2022
	BG	11.08.2022
Former [2022/49]	HR	11.05.2022
	LT	11.05.2022
	LV	11.05.2022
	BG	11.08.2022
Former [2022/47]	LT	11.05.2022
Cited in	International search	[A]WO2012036746 (MRSNY RANDALL J [US], et al);
		[XI]WO2015171965 (APPLIED MOLECULAR TRANSP LLC [US]);
	by applicant	US4414148
		US4458066
		US4569789
		US4589071
		US4659839
		US4671958
		US4680338
		US4683195
		US4699784
		US5272065
		US5807832
		US5917021
		US5922680
		US5997856
		US6007791
		US6086918
		US6133229
		US6174529
		US6255284
		US6391296
		US6525102
		US6573237
		US6592847
		US6613332
		US6673574
		US6759207
		US8877161
		WO2014US56177

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.32; 35p